Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Thus, these results supported the notion that the increased expression of miR-34a compensated for the absence of miR-449a in miR-449a-mutant mice.List of candidate targets of miR-34a and miR-449a predicted by miRDB.Predicted targets for mmu-miR-34a in miRDBPredicted targets for mmu-miR-449a in miRDBTarget ScoreGene SymbolGene DescriptionTarget ScoreGene SymbolGene Description100 Arhgap26 Rho GTPase activating protein 26100 Erc1 ELKS/RAB6-interacting/CAST family member 1100 Erc1 ELKS/RAB6-interacting/CAST family member 1100 Arhgap26 Rho GTPase activating protein 26100 Vamp2 vesicle-associated membrane protein 2100 Vamp2 vesicle-associated membrane protein 2100 Syt1 synaptotagmin I100 Syt1 synaptotagmin I99 E2f5 E2F transcription factor 599 E2f5 E2F transcription factor 599 Tbc1d2b TBC1 domain family, member 2B99 Fam76a family with sequence similarity 76, member A99 Fam76a family with sequence similarity 76, member A99 Tbc1d2b TBC1 domain family, member 2B99 Ppp2r5a protein phosphatase 2, regulatory subunit B′, alpha99 Mpp2 membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)99 Mpp2 membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)99 Ppp2r5a protein phosphatase 2, regulatory subunit B′, alpha99 Ppp1r11 protein phosphatase 1, regulatory (inhibitor) subunit 1199 Notch1 notch 199 Notch1 notch 198 Ttc19 tetratricopeptide repeat domain 1998 Ttc19 tetratricopeptide repeat domain 1998 Osgin2 oxidative stress induced growth inhibitor family member 298 Zfhx4 zinc finger homeodomain 498 Zfhx4 zinc finger homeodomain 498 Akap6 A kinase (PRKA) anchor protein 698 Slc6a1 solute carrier family 6 (neurotransmitter transporter, GABA), member 198 Abr active BCR-related gene98 Zfp644 zinc finger protein 64498 Camta1 calmodulin binding transcription activator 198 Camta1 calmodulin binding transcription activator 198 Slc6a1 solute carrier family 6 (neurotransmitter transporter, GABA), member 198 Abr active BCR-related gene98 Osgin2 oxidative stress induced growth inhibitor family member 298 Slc44a2 solute carrier family 44, member 298 Zfp644 zinc finger protein 64498 Akap6 A kinase (PRKA) anchor protein 697 Ubl4 ubiquitin-like 497 Mmp25 matrix metallopeptidase 2597 Hspb6 heat shock protein, alpha-crystallin-related, B697 Il6ra interleukin 6 receptor, alpha97 Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 197 Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)97 Il6ra interleukin 6 receptor, alpha97 Calcr calcitonin receptor97 Mmp25 matrix metallopeptidase 2597 Hspb6 heat shock protein, alpha-crystallin-related, B697 Pnoc prepronociceptin97 Ppp1r11 protein phosphatase 1, regulatory (inhibitor) subunit 1197 Mycn v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)97 Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 197 Tmem79 transmembrane protein 7997 Cbfa2t3 core-binding factor, runt domain, alpha subunit 2, translocated to, 3 (human)97 Zfp775 zinc finger protein 77597 4930544G11Rik RIKEN cDNA 4930544G11 gene97 Cbfa2t3 core-binding factor, runt domain, alpha subunit 2, translocated to, 3 (human)97 Ubl4 ubiquitin-like 497 Soga1 suppressor of glucose, autophagy associated 197 Pnoc prepronociceptin97 Fbxo30 F-box protein 3097 Tmem79 transmembrane protein 7997 Nfam1 Nfat activating molecule with ITAM motif 197 Arhgap1 Rho GTPase activating protein 197 Calcr calcitonin receptor97 Fbxo30 F-box protein 3097 Arhgap1 Rho GTPase activating protein 196 Cntn2 contactin 296 Ddx17 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1796 Ddx17 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1796 Ctnnd2 catenin (cadherin associated protein), delta 296 Mllt3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 396 Hexa hexosaminidase A96 Ctnnd2 catenin (cadherin associated protein), delta 296 Pacs1 phosphofurin acidic cluster sorting protein 196 Pacs1 phosphofurin acidic cluster sorting protein 196 Cuedc1 CUE domain containing 196 Hexa hexosaminidase A96 Mllt3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 395 Pogz pogo transposable element with ZNF domain96 Cntn2 contactin 295 Ppp2r3a protein phosphatase 2, regulatory subunit B″, alpha95 Pogz pogo transposable element with ZNF domain95 Sfmbt2 Scm-like with four mbt domains 295 Snx15 sorting nexin 1595 Dgkz diacylglycerol kinase zeta95 Tbl1xr1 transducin (beta)-like 1X-linked receptor 195 Tbl1xr1 transducin (beta)-like 1X-linked receptor 195 Dgkz diacylglycerol kinase zeta95 Lef1 lymphoid enhancer binding factor 195 Lef1 lymphoid enhancer binding factor 195 Satb2 special AT-rich sequence binding protein 295 Sfmbt2 Scm-like with four mbt domains 294 Astn1 astrotactin 194 Ahcyl2 S-adenosylhomocysteine hydrolase-like 294 Eml5 echinoderm microtubule associated protein like 594 Slc44a2 solute carrier family 44, member 294 Ranbp10 RAN binding protein 1094 Eml5 echinoderm microtubule associated protein like 594 Met met proto-oncogene94 Ranbp10 RAN binding protein 1094 Strn3 striatin, calmodulin binding protein 394 Astn1 astrotactin 194 Zmym4 zinc finger, MYM-type 494 Strn3 striatin, calmodulin binding protein 394 Hnf4a hepatic nuclear factor 4, alpha94 Met met proto-oncogene94 Rfx3 regulatory factor X, 3 (influences HLA class II expression)94 Hnf4a hepatic nuclear factor 4, alpha94 Ahcyl2 S-adenosylhomocysteine hydrolase-like 294 Rfx3 regulatory factor X, 3 (influences HLA class II expression)93 Pkp4 plakophilin 494 Zmym4 zinc finger, MYM-type 493 Ubp1 upstream binding protein 193 Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, member 793 Tmem255a transmembrane protein 255 A93 Tmem255a transmembrane protein 255 A93 Etl4 enhancer trap locus 493 Pkp4 plakophilin 493 Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, member 793 Tmem55a transmembrane protein 55 A92 Iqgap3 IQ motif containing GTPase activating protein 393 Ubp1 upstream binding protein 192 Nav3 neuron navigator 393 Etl4 enhancer trap locus 492 Trim67 tripartite motif-containing 6792 Scml2 sex comb on midleg-like 2 (Drosophila)92 Scml2 sex comb on midleg-like 2 (Drosophila)92 Taf5 TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor92 Papss2 3′-phosphoadenosine 5′-phosphosulfate synthase 292 Iqgap3 IQ motif containing GTPase activating protein 392 Taf5 TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor92 Uhrf2 ubiquitin-like, containing PHD and RING finger domains 292 Plcb1 phospholipase C, beta 192 Rtn4rl1 reticulon 4 receptor-like 192 Daam1 dishevelled associated activator of morphogenesis 192 Daam1 dishevelled associated activator of morphogenesis 192 Nat8l N-acetyltransferase 8-like92 Papss2 3′-phosphoadenosine 5′-phosphosulfate synthase 292 Rtn4rl1 reticulon 4 receptor-like 192 Plcb1 phospholipase C, beta 192 Uhrf2 ubiquitin-like, containing PHD and RING finger domains 292 Trim67 tripartite motif-containing 6792 Vdr vitamin D receptor92 Vdr vitamin D receptor92 Slc35g2 solute carrier family 35, member G292 4930544G11Rik RIKEN cDNA 4930544G11 gene91 Coro1c coronin, actin binding protein 1 C92 Nav3 neuron navigator 391 Stag3 stromal antigen 392 Nat8l N-acetyltransferase 8-like91 H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)91 Lzts3 leucine zipper, putative tumor suppressor family member 391 Crkl v-crk sarcoma virus CT10 oncogene homolog (avian)-like91 Stag3 stromal antigen 391 Soga1 suppressor of glucose, autophagy associated 191 Pea15a phosphoprotein enriched in astrocytes 15 A91 Vat1 vesicle amine transport protein 1 homolog (T californica)91 Padi2 peptidyl arginine deiminase, type II91 Padi2 peptidyl arginine deiminase, type II91 H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)91 Pea15a phosphoprotein enriched in astrocytes 15 A91 Coro1c coronin, actin binding protein 1 C91 Rps6ka4 ribosomal protein S6 kinase, polypeptide 491 Rps6ka4 ribosomal protein S6 kinase, polypeptide 491 Frk fyn-related kinase91 Frk fyn-related kinase90 Tanc2 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 291 Vat1 vesicle amine transport protein 1 homolog (T californica)90 Ing5 inhibitor of growth family, member 591 Crkl v-crk sarcoma virus CT10 oncogene homolog (avian)-like90 Tmem25 transmembrane protein 2590 Itsn1 intersectin 1 (SH3 domain protein 1 A)90 Itsn1 intersectin 1 (SH3 domain protein 1 A)90 Tmem25 transmembrane protein 2590 Car7 carbonic anhydrase 790 Ing5 inhibitor of growth family, member 590 Ccne2 cyclin E290 Gpr158 G protein-coupled receptor 15890 Gpr158 G protein-coupled receptor 15890 Tanc2 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 290 Map1a microtubule-associated protein 1 A90 Pdgfrb platelet derived growth factor receptor, beta polypeptide89 Cuedc1 CUE domain containing 190 Car7 carbonic anhydrase 789 Zfp120 zinc finger protein 12090 Ccne2 cyclin E289 Tom1 target of myb1 homolog (chicken)89 Srpr signal recognition particle receptor (‘docking protein’)89 Patz1 POZ (BTB) and AT hook containing zinc finger 189 Zfp120 zinc finger protein 12089 Srpr signal recognition particle receptor (‘docking protein’)89 Satb2 special AT-rich sequence binding protein 289 Vwa5b2 von Willebrand factor A domain containing 5B289 Tom1 target of myb1 homolog (chicken)89 S1pr3 sphingosine-1-phosphate receptor 389 Casp2 caspase 289 Nfam1 Nfat activating molecule with ITAM motif 189 S1pr3 sphingosine-1-phosphate receptor 389 Casp2 caspase 289 Vwa5b2 von Willebrand factor A domain containing 5B288 Scn2b sodium channel, voltage-gated, type II, beta89 Patz1 POZ (BTB) and AT hook containing zinc finger 188 Sar1a 88 Sar1a SAR1 gene homolog A (S. cerevisiae)88 Nup210 nucleoporin 21088 Rragc Ras-related GTP binding C88 Pdgfra platelet derived growth factor receptor, alpha polypeptide88 Scn2b sodium channel, voltage-gated, type II, beta88 Nrip3 nuclear receptor interacting protein 388 Nup210 nucleoporin 21088 Ddn dendrin88 Pdgfra platelet derived growth factor receptor, alpha polypeptide88 Rragc Ras-related GTP binding C88 Ddn dendrin87 Scamp4 secretory carrier membrane protein 488 Nrip3 nuclear receptor interacting protein 387 Tgif2 TGFB-induced factor homeobox 287 Fam167a family with sequence similarity 167, member A87 Ltbp2 latent transforming growth factor beta binding protein 287 Fam46a family with sequence similarity 46, member A87 Fam46a family with sequence similarity 46, member A87 Wasf1 WAS protein family, member 187 Wasf1 WAS protein family, member 187 Ltbp2 latent transforming growth factor beta binding protein 287 Fam167a family with sequence similarity 167, member A87 Tgif2 TGFB-induced factor homeobox 287 Stk10 serine/threonine kinase 1087 Scamp4 secretory carrier membrane protein 486 Gmfb glia maturation factor, beta87 Stk10 serine/threonine kinase 1086 Metap1 methionyl aminopeptidase 186 Metap1 methionyl aminopeptidase 186 Fam131b family with sequence similarity 131, member B86 Dpysl4 dihydropyrimidinase-like 486 Celf3 CUGBP, Elav-like family member 386 Gmfb glia maturation factor, beta86 Lman1 lectin, mannose-binding, 186 Lman1 lectin, mannose-binding, 186 Angpt1 angiopoietin 186 Ppp2r3a protein phosphatase 2, regulatory subunit B″, alpha86 Isg20 interferon-stimulated protein86 Celf3 CUGBP, Elav-like family member 385 Usf1 upstream transcription factor 186 Fam131b family with sequence similarity 131, member B85 Gpr165 G protein-coupled receptor 16585 Dip2c DIP2 disco-interacting protein 2 homolog C (Drosophila)85 Gmnc geminin coiled-coil domain containing85 Gpr165 G protein-coupled receptor 16585 Synj1 synaptojanin 185 Sec61a1 Sec61 alpha 1 subunit (S. cerevisiae)85 Dip2c DIP2 disco-interacting protein 2 homolog C (Drosophila)85 Gmnc geminin coiled-coil domain containing85 Rnf4 ring finger protein 485 Synj1 synaptojanin 185 Sec61a1 Sec61 alpha 1 subunit (S. cerevisiae)85 Usf1 upstream transcription factor 185 Rnf4 ring finger protein 4
Source: Expression of miR-34a was increased in miR-449aIns/Ins thymus. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
TSC (thymic epithelial progenitor cell line) cells were established in our lab previously.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
microRNA-449a modulates medullary thymic epithelial cell differentiation
Study design awaiting verification · Scientific Reports · 2017
Original publication title
microRNA-449a modulates medullary thymic epithelial cell differentiation
© The Author(s) 2017
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Medullary thymic epithelial cells (mTECs) ectopically express a diversity of peripheral tissue-restricted antigens (PTAs) and provide unique cues for the expansion, maturation and selection of a repertoire of functionally diverse T lymphocytes. Genetic deletion of all mature microRNAs in thymic epithelial cells (TECs) results in premature thymic involution, progressive disorganisation of the thymic epithelium, and alteration in thymic T cell lineage commitment, consequently eliciting autoimmune disorders. In the present study, we identified that microRNA-449a (miR-449a), a member of miR-449 cluster, regulated mTEC differentiation.
Expression of miR-449a was induced by RANK ligand in mouse fetal thymus. In in vitro studies, overexpression of miR-449a induced thymic epithelial progenitor cells (TEPCs) differentiation into mature mTECs. Despite abundant expression of miR-449a in developing thymus, miR-449a-mutant mice exhibited normal thymic development. This might be partially due to in miR-449a-mutant thymus the up-regulation of miR-34a which shared similar seed sequence with miR-449a. However, thymic expression of miR-449/34 sponge which was able to neutralize the function of miR-449/34 family members significantly reduced the number of mature Ly51-MHCIIhi mTECs.
Taken together, our data suggested that miR-449a modulated mTEC differentiation, and members of miR-34 cluster functioned redundantly to rescue miR-449a deficiency in thymus development.
Authors’ abstract
Medullary thymic epithelial cells (mTECs) ectopically express a diversity of peripheral tissue-restricted antigens (PTAs) and provide unique cues for the expansion, maturation and selection of a repertoire of functionally diverse T lymphocytes. Genetic deletion of all mature microRNAs in thymic epithelial cells (TECs) results in premature thymic involution, progressive disorganisation of the thymic epithelium, and alteration in thymic T cell lineage commitment, consequently eliciting autoimmune disorders. In the present study, we identified that microRNA-449a (miR-449a), a member of miR-449 cluster, regulated mTEC differentiation.
Expression of miR-449a was induced by RANK ligand in mouse fetal thymus. In in vitro studies, overexpression of miR-449a induced thymic epithelial progenitor cells (TEPCs) differentiation into mature mTECs. Despite abundant expression of miR-449a in developing thymus, miR-449a-mutant mice exhibited normal thymic development. This might be partially due to in miR-449a-mutant thymus the up-regulation of miR-34a which shared similar seed sequence with miR-449a. However, thymic expression of miR-449/34 sponge which was able to neutralize the function of miR-449/34 family members significantly reduced the number of mature Ly51-MHCIIhi mTECs.
Taken together, our data suggested that miR-449a modulated mTEC differentiation, and members of miR-34 cluster functioned redundantly to rescue miR-449a deficiency in thymus development.
Publication and source details
Original title: microRNA-449a modulates medullary thymic epithelial cell differentiation
Pengfei Chen; Haohao Zhang; Xiaohua Sun; Yiming Hu; Wenxia Jiang; Zhanjie Liu; Sanhong Liu; Xiaoren Zhang
Scientific Reports · 2017
© The Author(s) 2017https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T19:23:22.149246+00:00
DOI: 10.1038/s41598-017-16162-2 · PMC5698406